0G8X.LImmunovia AB

Über

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

www.immunovia.com

Kennzahlen

Marktkapitalisierung

66.38M

EPS

-0.42

Dividendenrendite

0.00%

Beta

2.68

KBV

1.21

EK-Rendite

-225.4%

Sektor

Healthcare

Branche

Medical - Pharmaceuticals

CEO

Jeff Borcherding

Mitarbeiter

13

IPO-Datum

2018-01-26

Land

SE